Humacyte, Inc. Shareholders' Equity
Humacyte, Inc. (HUMA) had Shareholders' Equity of $31.26 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $31.26M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $11.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.11M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$4.75M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $31.26M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $11.62M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $3.11M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$4.75M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $4.05M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $36.04M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | -$52.67M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | -$63.72M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$28.29M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $26.15M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $13.55M 10-K · filed 2026-03-27 | |
| 2023-09-30 | $36.99M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $61.12M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $81.89M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $116.93M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $118.67M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $142.26M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $103.89M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $122.17M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $75.86M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$379.76M 10-Q · filed 2022-11-10 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$365.52M 10-Q · filed 2022-11-10 | $5.00M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$350.32M 10-K · filed 2023-03-24 | $5.00M 10-K · filed 2021-02-16 |
| 2020-09-30 | -$335.40M 10-Q · filed 2021-11-15 | $5.00M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$318.82M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$305.11M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$288.79M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |